AI for IBD is gradually improving clinical care for gastroenterologists, but it comes with challenges, such as cost and ...

Fidaxomicin use in the treatment of CDI has significantly increased since the IDSA 2021 Clinical Guideline Update; however, its use is still low.

An abnormally large colon among individuals with IBS-C and functional constipation could help predict impaired manometric response.

For patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC), chemoradiotherapy (CRT) followed by immunochemotherapy (iCT) and then surgery is promising.

Asian American, Native Hawaiian, and Pacific Islander (AANHPI) patients with early-stage hepatocellular carcinoma (HCC) have significantly better survival outcomes compared with non-Hispanic White ...

Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and diabetes.

Supplementation with cholecalciferol 1,000 IU/day during pregnancy is associated with greater offspring bone mineral density during childhood.

Placebo rates in induction and maintenance trials for Crohn disease (CD) were generally increased for clinical response compared with clinical remission, according to a study in Gastroenterology.

Higher physical activity (PA) levels can increase life expectancy, according to a study published online Nov. 14 in the British Journal of Sports Medicine. Lenn ...

Low anti-TNF levels during infliximab or adalimumab maintenance treatment are linked to increased risk for treatment failure in pediatric CD.

Risk factors for IBS may include HIV infection; however, additional large-scale studies are necessary to draw sound conclusions.

Adverse childhood experiences (ACEs) are common globally, according to a review published online Nov. 11 in JAMA Pediatrics. Sheri Madigan, Ph.D., from Universi ...